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mammals,	 there	 are	 39	 Hox	 genes	 organized	 into	 four	 complexes	 (HoxA-D)	 located	 on	 separate	
chromosomes.	 Based	 on	 sequence	 similarity	 and	 relative	 position	 along	 the	 clusters,	Hox	 genes	 have	
been	 subdivided	 into	 13	 paralogue	 groups.	Hox	 genes	 have	 been	 characterized	 as	 master	 regulatory	
genes	in	development	as	they	were	initially	found	to	play	key	roles	in	determining	the	identity	of	body	
segments	along	the	main	body	and	appendicular	axes	of	bilaterian	embryos.	Accordingly,	in	many	cases,	
Hox	 mutations	 lead	 to	 homeotic	 transformations	 meaning	 that	 developing	 structures	 in	 the	 embryo	
take	on	the	identity	of	distinct,	usually	adjacent	ones	along	the	rostro-caudal	axis	(reviewed	in	[1]).	For	
example,	knockout	mice	for	Hoxa2	display	cranial	transformations	caused	by	the	replacement	of	second	





modulate	 their	 DNA	 binding	 specificity	 [5,6]	 and	 transcription	 activity	 [7,8]	 or,	 conversely,	 which	 are	
affected	 by	 the	Hox	 interaction	 [9].	 Nonetheless,	 data	 about	 Hox	 partner	 proteins	 remain	 scarce,	 the	
only	 well-documented	 interactions	 being	 these	 involving	 members	 of	 the	 PBC,	 MEIS	 or	 PREP	 family	
(reviewed	 in	 [10]).	 Additional	 levels	 of	 regulation	 of	 transcription	 factor	 activity	 by	 post-translational	
modifications	 are	 well-known	 but	 are	 again	 poorly	 characterized	 for	 HOX	 proteins.	 Among	 the	 few	
known	 instances,	 both	 in	 drosophila	 and	 mammals,	 phosphorylation	 of	 several	 HOX	 proteins	 (ANTP,	
UBX,	HOXA9,	and	HOXB7)	by	casein	kinase	II	has	been	shown	to	be	essential	to	their	activities	[11-14].	
The	 PKC-mediated	 phosphorylation	 of	 HOXA9	 decreases	 its	 DNA	 binding	 and	 its	 ability	 to	 form	
cooperative	DNA	binding	complexes	with	PBX	 [14].	Conversely,	 tyrosine	dephosphorylation	of	HOXA10	
by	 SHP1-2	 increases	 its	 DNA	 binding	 affinity	 and	 consequently	 affects	 transcriptional	 regulation	 of	 its	
target	 genes	 [15,16].	 Upon	 binding	 to	 PARP-1,	 HOXB7	 and	 HOXA7	 are	 poly(ADP-ribosyl-)ated	 which	
results	 in	 the	 reduction	 of	 both	 DNA-binding	 and	 transcriptional	 activity	 [17].	 HOXA9	 methylation	 is	
mediated	 by	 PRMT5	 leading	 to	 an	 induction	 of	 HOXA9	 targets	 [18].	 The	 PCAF	 enzyme	 acetylates,	
decreases	the	activity	and	destabilizes	HOXA10	[19].		
Ubiquitination	 is	 a	 versatile	 post-translational	 modification	 involved	 in	 several	 cell	 processes	 such	 as	
proteasomal	 protein	 degradation,	 cell	 signalling,	 membrane	 trafficking	 or	 DNA	 damage	 response	
(reviewed	 in	 [20]).	 The	ubiquitin	polypeptide	addition	 to	 target	proteins	 is	 carried	out	by	a	 three-step	
enzymatic	 cascade:	 ubiquitin	 is	 first	 activated	 by	 an	 E1	 ubiquitin-activating	 enzyme,	 transferred	 to	 an	
E2	 ubiquitin-conjugating	 enzyme,	 and	 then	 bound	 to	 the	 substrate	 by	 a	 specific	 E3	 ubiquitin	 ligase.	
Multiple	 HOX	 proteins	 have	 been	 reported	 to	 be	 post-translationally	 ubiquitinated	 by	 the	 CUL4	
ubiquitin	 ligase	 promoting	 their	 proteasome-dependent	 degradation	 [21,22].	 Similarly,	 HOXC10	might	
be	 regulated	 by	 the	 anaphase	 promoting	 complex	 (APC)	 in	 an	 ubiquitin-dependent	 and	 proteasomal	
manner	and	its	abundance	was	shown	to	oscillate	during	the	cell	cycle	[23].		
In	 total,	 data	 concerning	 the	 regulation	 of	 HOX	 protein	 relating	 to	 their	 transcriptional	 activity,	




regulation	 of	 HOX	 activity	 [24,25].	 Within	 a	 similar	 framework,	 we	 recently	 conducted	 a	 yeast	 two-
hybrid	 screening	 for	 candidate	 interactors	 of	 Hoxa2.	 We	 thereby	 identified	 RCHY1,	 an	 E3	 ubiquitin	
ligase	 targeting	 apoptosis	 and	 cell	 cycle	 regulators,	 but	 surprisingly	 this	 interaction	 does	 not	 seem	 to	
lead	to	Hoxa2	activity	modulation	or	degradation	but	instead	impacts	RCHY1	stability	itself	[26].		
Here,	we	 report	a	novel	 interaction	 involving	Hoxa2	and	a	 subunit	of	 the	KPC	complex,	KPC2.	The	KPC	
(kip1	 ubiquitination	 promoting	 complex)	 complex	 consists	 in	 2	 subunits:	 KPC1	 and	 KPC2	 [27].	 KPC1,	 a	
ring	 finger	 domain-containing	 protein,	 functions	 as	 the	 catalytic	 E3	 ubiquitin	 ligase	 subunit	 of	 the	
complex	 [27].	 KPC2	 is	 considered	 to	 be	 the	 adapter	 subunit	 of	 the	 complex	 as	 it	 stabilizes	 KPC1,	 and	
interacts	 both	 with	 poly-ubiquitinated	 proteins	 and	 the	 proteasome	 [27,28].	 The	 KPC	 complex	
influences	 cell	 cycle	 via	 p27Kip1	 regulation	 [27],	 a	 cyclin-dependent	 kinase	 inhibitor	 promoting	 the	
G1/S	 transition.	 KPC	 was	 shown	 to	 interact	 with	 the	 cytoplasmic	 form	 of	 p27Kip1	 (pp27ser10),	
mediating	 its	ubiquitination	and	leading	to	 its	proteasomal	degradation	[27-30].	Our	data	 indicate	that	
contrarily	 to	 its	 negative	 impact	 on	 p27Kip1	 stability,	 the	 KPC	 complex	 does	 not	 seem	 to	 negatively	
regulate	HOXA2	stability	but	instead	impacts	on	its	cellular	distribution	and	transcriptional	activity.	We	











kindly	 provided	 by	 F.	 Rijli	 (Friedrich	 Miescher	 Institute,	 Switzerland),	 that	 for	 p27Kip1	 and	 KPC1	
templates	 were	 received	 from	 L.	 Nguyen	 (University	 of	 Liege,	 Belgium)	 and	 I.	 Nakayama	 (Kyushu	
University,	Japan),	respectively.	Sequences	coding	for	Hoxa2	deletion	derivatives	as	well	as	for	HOXB1,	
HOXB2,	 p27Kip1	 and	 KPC1,	 were	 PCR-amplified	 using	 the	 primers	 listed	 in	 Table	 1	 and	 previously	
described	 templates.	 The	 resulting	 PCR	 products	 were	 inserted	 into	 the	 pDON223	 vector	 using	 the	
Gateway®	Technology	 from	 Invitrogen	 to	 generate	 the	 corresponding	pEnt	 vectors.	 The	 resulting	pEnt	
plasmids	 were	 confirmed	 by	 DNA	 sequencing	 and	 used	 to	 generate	 yeast	 expression	 vectors	 for	 AD-
KPC2	 and	 DB-KPC2	 (pDEST-AD	 and	 pDEST-DB	 destination	 vectors,	 Gateway®,	 Invitrogen);	 mammalian	




genomic	DNA	using	 the	 following	 primers,	AATCCGCTTAACAGCACCCA	 and	 TGCTCTGGGCAGAGACAATG.	







with	 10	%	 fetal	 bovine	 serum	 (#10270-106,	 Invitrogen),	 100	 U/ml	 of	 penicillin-streptomycin	 (#15140-
122,	GIBCO)	and	1	mM	sodium	pyruvate	(11360-070,	GIBCO).	COS-7	cells	were	maintained	in	Dulbecco’s	
Modified	Eagle	Medium	(D-MEM)	(#31885-023,	GIBCO)	supplemented	with	10	%	fetal	bovine	serum	and	
100	 U/ml	 of	 penicillin-streptomycin	 (#15140-122,	 GIBCO).	 Plasmid	 constructs	 were	 transfected	 with	
jetPRIME	 transfection	 reagent	 (#114-07,	 Polyplus-transfection)	 according	 to	 the	 manufacturer's	
instructions.	For	proteasome	inhibition,	24	h	after	transfection,	cells	were	treated	with	5-10	µM	MG132	
dissolved	 in	DMSO	 (#474790,	Calbiochem)	or	with	DMSO	as	 control	 for	periods	of	7-15	h.	 For	half-life	
measurements,	 24	 h	 after	 transfection,	 the	 proteasome	was	 inhibited	 for	 4	 h	 as	 previously	 described	
then	 treated	with	 200	 µg/ml	 of	 cycloheximide	 (#01810,	 Sigma)	 dissolved	 in	 DMSO	 following	 different	
exposure	 times.	 For	nuclear	export	 inhibition,	8	h	after	 transfection,	 cells	were	 treated	with	10	ng/ml	
leptomycine	B	in	DMSO	(#L2913,	Sigma),	or	with	DMSO	as	control,	for	a	period	of	16	h.		
Protein	abundance	analysis	and	Western	Blot	
HEK293T	were	 transfected	with	 distinct	 combinations	 of	 expression	 vectors,	 at	 500	 ng	 each.	 To	 keep	
the	 amount	 of	 transfected	 DNA	 constant,	 the	 total	 amount	 of	 DNA	was	 adjusted	with	 the	 pDestGST.	
Cells	were	lysed	for	20	minutes	at	4	°C	in	ice-cold	IPLS	lysis	buffer	(0.5	%	NP-40,	20	mM	Tris-HCl	pH	7.5,	
0.5	 mM	 EDTA,	 120	 mM	 NaCl,	 10	 %	 glycerol)	 containing	 protease	 inhibitor	 cocktail	 (#11873580001,	
Roche).	 Cells	 lysates	 were	 centrifuged	 for	 5	minutes	 at	 1000	 g	 at	 4°C.	 Supernatants	 were	 recovered,	
equal	 amounts	 of	 proteins	 were	 boiled	 5	 min	 at	 95°C	 in	 Laemmli	 loading	 buffer	 (10	 %	 SDS,	 30	 %	
glycerol,	 350	mM	Tris-Cl	 pH	 6.8,	 600	mM	DTT,	 0.1	%	bromophenol	 blue)	 and	 loaded	on	 SDS-PAGE	 for	
electrophoresis.	 Proteins	 were	 then	 transferred	 onto	 a	 nitrocellulose	 membrane	 (#10600002,	
Amersham	 Biosciences).	 Membranes	 were	 blocked	 in	 10	 %	 low-fat	 milk.	 Anti-FLAG	 primary	 antibody	
(M2)	 (#F1804,	 Sigma)	 and	 anti-GST	 primary	 antibody	 (GST-2)	 (#G1160,	 Sigma)	 were	 used	 at	 1:5000	






HEK293T	 cells	 were	 transfected	 with	 500	 ng	 of	 FLAG-HOXA2	 and	 500	 ng	 of	 GST	 alone	 or	 GST-KPC2	
vectors.	Forty-eight	hours	after	transfection,	cells	were	lysed	for	20	minutes	at	4	°C	in	ice-cold	IPLS	lysis	
buffer	 including	protease	 inhibitor	cocktail	 (#11873580001,	Roche.	Cells	 lysates	were	centrifuged	for	5	
min	at	1000	g	at	4°C.	Supernatants	were	recovered	and	samples	were	incubated	overnight	on	a	rotating	
wheel	 at	 4°C	 with	 glutathione-agarose	 beads	 (#G4510,	 Sigma)	 pre-washed	 three	 times	 with	 ice-cold	
IPLS	 lysis	 buffer.	 Beads	 were	 washed	 three	 times	 with	 ice-cold	 IPLS.	 Beads	 were	 supplemented	 with	
Laemmli	 loading	 buffer	 for	 SDS-PAGE	 and	 boiled	 5	 minutes	 at	 95	 °C.	 Samples	 were	 centrifuged	 and	
analyzed	 by	Western	 blotting.	 As	 controls,	 in	 parallel	 to	 protein	 co-precipitation,	 expression	 of	 fusion	
proteins	was	confirmed	by	Western	blotting.	
Bimolecular	Fluorescence	Complementation	assay	(BiFC)	
COS-7	 cells	 were	 cultured	 on	 glass	 coverslips	 and	 transtected	 24	 h	 after	 plating	 with	 distinct	
combinations	 of	 pExpVN173	 and	 pExpVC155	 vectors	 for	 the	 fusion	 proteins	 to	 be	 tested	 and/or	
pDestVN173	and	pDestVC155	empty	controls,	each	at	500	ng.	Twenty-four	hours	after	 transfection,	cells	
were	 rinsed	 in	 PBS	 solution	 and	 fixed	 for	 20	 minutes	 with	 4%	 paraformaldehyde	 (PFA)	 in	 PBS,	 then	





%	PFA	 in	PBS.	Cells	were	 further	blocked	with	10	%	 low-fat	milk	 in	TBS-0.1	%	Triton	X100	 solution	 for	
30-45	minutes	at	RT,	followed	by	overnight	incubation	in	TBS-0.1%	Triton	X100-1%	low-fat	milk	solution	
at	 4°C,	 with	 mouse	 anti-FLAG	 (M2)	 (#F1804,	 Sigma),	 rabbit	 anti-GST	 (#G7781,	 Sigma)	 or	 rabbit	 anti-
HOXA2	 (#HPA029774,	 Sigma)	 used	 at	 1:100.	 Cells	were	 rinsed	 three	 times	 for	 10	minutes	 in	 TBS-0.1%	





Glass	 coverslips	 were	 mounted	 in	 Vectashield®-DAPI	 medium	 (Vector	 laboratories).	 Slides	 were	 then	
analyzed	by	epifluorescence	(Axioskop	2,	Zeiss)	or	confocal	microscopy	(LSM710,	Zeiss,	Jena,	Germany).	
Fluorescence	 signals	 were	 quantified	 using	 ImageJ	 software.	 BiFC	 fluorescence	 from	 the	 test	 and	 the	




of	 Hoxa2	 and/or	 75	 ng	 of	 GST-KPC2	 vectors.	 To	 avoid	 experimental	 variations	 due	 to	 transfection	
efficiency,	 an	 internal	 standard	 reporter	 corresponding	 tothe	 lacZ	 gene	 under	 the	 control	 of	 a	
constitutive	 CMV	 promoter	 (pCMVlacZ,	 [21])	 was	 also	 added	 in	 cotransfection	 experiments	 (25	 ng).	
Cells	were	harvested	48	h	after	transfection	for	enzymatic	assays.	Lysis	and	enzymatic	activity	dosages	
were	 performed	 with	 the	 β-gal	 reporter	 gene	 assay	 kit	 (#11758241001,	 Roche)	 and	 the	 luciferase	
reporter	 gene	 assay	 kit	 (#11	669893001,	Roche),	 respectively.	 Luciferase	 activity	was	 then	normalized	
to	that	of	β-galactosidase.	
In	situ	Hybridization	(ISH),	RNA	extraction	and	RT-PCR	from	mouse	embryos.	
Experimental	 procedures	on	 animals	were	performed	 in	 accordance	with	 the	 guidelines	of	 the	Animal	
Experimentation	Ethics	Committee	of	 the	Université	 catholique	de	 Louvain	and	 in	agreement	with	 the	
European	 directive	 2010/63/UE.	Mice	 were	maintained	 and	 fed	 under	 standard	 conditions	 on	 a	 14	 h	
light/10	h	dark	cycle.	All	 the	experiments	were	carried	out	on	adult	CD1	 female	mice	mated	overnight	
with	 adult	 CD1	males.	When	 plugs	were	 detected,	 pregnant	mice	were	 killed	 10.5	 or	 11.5	 days	 post-
coitus	 by	 gas	 inhalation	 and	 embryos	were	 rapidly	 dissected	while	 kept	 on	 ice.	 Embryos	 for	 ISH	were	
rinsed	 in	 PBS,	 fixed	 overnight	with	 4	%	 PFA	 in	 PBS	 at	 4	 °C,	 rinsed	 three	 times	 20	minutes	 in	 PBS.	 For	
cryopreservation,	embryos	were	 incubated	2h	in	10	%	sucrose/PBS	and	overnight	 in	20	%	sucrose/PBS,	
then	 embedded	 in	OCT	medium	 (Shandon	 CryomatrixTM,	 Thermo	 Electron,	 France),	 frozen	 on	 dry	 ice	
and	stored	at	-80	°C.	
Seven	 sets	 of	 20	 µm	 serial	 transversal	 or	 sagittal	 cryosections	 per	 embryos	 were	 cut	 on	 a	 Leica	 CM	
3050S	 cryostat.	 Gene	 expression	 was	 detected	 using	 digoxigenin-labelled	 RNA	 probes	 as	 previously	
described	by	Hutlet	et	al.	2014	[40].	
For	probe	synthesis,	the	pKS-Hoxa2	and	the	pCR2.1-TOPO-Kpc2	plasmid	were	linearized	with	EcoRI	and	
SpeI,	 respectively,	 and	 the	probes	were	 transcribed	with	 the	T3	and	 the	T7	polymerases,	 respectively.	
Hybridized	 sections	were	analyzed	on	a	 Leica	DM2500	microscope,	 and	pictures	were	 captured	with	a	
Leica	DFC420C	camera.	
For	the	immunochemistry	on	the	hybridized	sections,	the	slides	were	processed	as	previously	described	
for	 the	 immunocytofuorescence.	 The	 anti-islet1/2	 antibody	 was	 used	 at	 a	 1/500	 dilution	 (#39.4D5,	
DSHB).	
Total	RNA	was	extracted	with	the	High	Pure	RNA	 Isolation	Kit	 (Roche)	according	to	the	manufacturer's	
instructions.	 RNA	 was	 reverse	 transcribed	 using	 a	 reaction	 mix	 containing	 200	 ng	 random	 hexamer	
primers	 (#SO142,	 Life	 technologies),	 1	 mM	 dNTP	 (#R0191,	 Life	 technologies),	 10	 U	 riboLock	 RNase	
inhibitor	 (#EO0381,	 Life	 technologies),	 100	U	RevertAid	Reverse	 transcriptase	and	 the	provided	buffer	
(#EP0441,	Life	technologies).	The	mixture	was	incubated	10	minutes	at	25°C,	1	h	at	42°C	and	10	minutes	
at	 80°C.	 Specific	 intron-spanning	 primers	 were	 designed	 based	 on	 NCBI	 database	 sequences	 listed	 in	
Table	2.	PCR	reaction	mix	contained	1.25	U	Taq	DNA	Polymerase	(#EP0402,	Life	technologies)	with	the	
provided	buffer	supplemented	with	1.9	mM	MgCL2,	250	µM	dNTP	(#R0191,	Life	technologies)	and	1.25	
mM	 of	 each	 primer.	 The	 amplification	 program	 started	with	 an	 activation	 step	 at	 95°C	 for	 5	minutes	
followed	 by	 35	 cycles	 of	 denaturation	 at	 95	 °C	 for	 30	 seconds,	 hybridization	 at	 primers	 specific	
temperatures	 (Table	 2)	 for	 15	 seconds	 and	 elongation	 at	 72	 °C	 for	 45	 seconds.	 The	 last	 cycle	 was	
completed	by	a	final	elongation	step	at	72	°C	for	7	minutes.	For	Hoxa2	amplification,	PCR	reaction	mix	
contained	 1	 U	 Expand	 Long	 Template	 (Rcohe)	with	 the	 provided	 buffer	 (n°1),	 400	 µM	 dNTP	 (#R0191,	
Life	 technologies)	 and	 250	 nM	 of	 each	 primer.	 The	 amplification	 program	 started	 with	 an	 activation	
step	at	95°C	for	5	minutes	followed	by	35	cycles	of	denaturation	at	95°C	for	30	seconds,	hybridization	at	
55	 °C	 for	 15	 seconds	 and	 elongation	 at	 68°C	 for	 45	 seconds.	 The	 last	 cycle	 was	 completed	 by	 a	 final	
elongation	step	at	68°C	for	7	minutes.	
Statistical	analysis		
All	 statistical analyses	 were	 performed	 with	 JMP11	 software.	 Luciferase	 activation	 and	 HOXA2	
subcellular	 distribution	 were	 analyzed	 using	 a	 mixed	 model	 using	 the	 experiment	 as	 a	 random	







ORFeome	 v3.1,	 an	 extensive	 set	 of	 cloned	 human	 open	 reading	 frames.	 The	 complete	 ORFeome	was	
tested	against	Hoxa2,	and	KPC2	was	 identified	as	a	candidate	Hoxa2	 interactor.	To	validate	the	Hoxa2-
KPC2	interaction,	co-precipitation	of	proteins	was	assayed	from	transiently	transfected	HEK293T	cells.	A	
FLAG-Hoxa2	 fusion	protein	was	 co-expressed	with	 glutathione	 S-transferase	 (GST)-tagged	KPC2,	which	
was	 specifically	 precipitated	 using	 glutathione-agarose	 beads.	 In	 the	 presence	 of	 GST-KPC2,	 a	 band	
corresponding	 to	 FLAG-Hoxa2	was	 detected	 by	western	 blotting	 demonstrating	 that	 the	 two	 proteins	
can	 form	 a	 complex	 in	 HEK293T	 cells	 (Figure	 1).	 As	 a	 negative	 control,	 when	 an	 unfused	 GST	
polypeptide	was	 expressed	 in	 combination	with	 FLAG-Hoxa2,	Western	blotting	detection	 for	 the	 FLAG	
epitope	showed	little	or	no	signal.		
Different	isoforms	of	Kpc2	are	expressed	during	mouse	embryonic	development	
The	 data	 above	 indicate	 that	 HOXA2	 and	 KPC2,	 once	 co-expressed	 in	 cells,	 are	 able	 to	 interact.	
Consequently,	 it	 was	 of	 interest	 to	 investigate	 whether	 this	 interaction	 could	 take	 place	 in	 a	
physiological	context,	i.e.	to	determine	if	both	genes	show	overlapping	expression.	As	Hoxa2	expression	
and	 functions	 have	 essentially	 been	 described	 during	 mouse	 embryogenesis	 and,	 more	 specifically,	
after	 gastrulation,	 we	 investigated	 whether	 Kpc2	 is	 also	 expressed	 between	 E8.5	 to	 E12.5.	 First,	 to	
provide	 a	 qualitative	 response	 as	 to	 the	 expression	 of	 Kpc2	 gene	 in	 mouse	 embryos,	 RT-PCRs	 were	
performed	on	different	pools	of	embryonic	cDNA	using	primers	designed	on	the	7th	and	the	10th	exons	
of	 Kpc2	 (Figure	 2A-B).	 The	 PCR	 amplification	 provided	 3	 DNA	 fragments	 that	 could	 correspond	 to	
different	isoforms	(Figure	2A-B).	To	experimentally	verify	that	these	fragments	correspond	to	Kpc2,	the	
PCR	products	were	sequenced	(Supplemental	Figure	1).	The	upper	band	corresponded	to	the	validated	




Kpc2	 presents	 a	 restricted	 expression	 pattern	 in	 E10.5	 and	 E11.5	 mouse	 embryos	 which	 partially	
overlaps	with	that	for	Hoxa2	
As	Kcp2	 is	expressed	at	different	embryonic	stages	 in	mouse,	we	were	 interested	 in	 further	examining	
the	Kpc2	 transcript	distribution	and	whether	Hoxa2	and	Kpc2	patterns	overlap.	We	therefore	analyzed	
the	expression	of	Kpc2	mRNA	on	 sagittal	 and	 transversal	 sections	 in	 E10.5	and	E11.5	mouse	embryos.	
Kpc2	 expression	 showed	 a	 similar	 restricted	 profile	 at	 both	 E10.5	 (Figure	 2C,	 K,	 M,	 O,	 Q)	 and	 E11.5	
(Figure	2D,	E,	G,	I,	S,	U).	Abundant	Kpc2	expression	was	consistently	detected	in	the	ventral	neural	tube	
(Figure	 2H/J/R/V).	 Caudally,	 Kpc2	mRNA	was	 also	 detected	 in	 dorsal	 root	 ganglia	 (Figure	 2E,	G,	Q,	U).	
Moreover,	 its	 expression	 was	 observed	 on	 either	 sides	 of	 the	 otic	 vesicle	 (OT)	 corresponding	 to	 the	
facio-acoustic	 (VII-VIII)	 ganglion	 complex	 and	 the	 superior	 and	 inferior	 glossopharyngeal	 (IX)	 ganglia	
(Figure	2C,	O,	D,	S).	
Observation	 of	 Kpc2-positive	 cells	 in	 the	 ventral	 area	 (Figure	 2G,	 I,	 Q,	 U)	 and	 on	 either	 sides	 of	 the	
neural	 tube	 (Figure	 2E,	 G,	 Q,	 U)	 could	 correspond	 to	 expression	 in	 motor	 neurons	 and	 dorsal	 root	
ganglia,	 respectively.	 To	 test	 this	 possibility,	 we	 performed	 immunofluorescence	 staining	 of	 E11.5	
embryo	with	anti-Islet-1/2	antibody,	a	marker	of	the	motor	neurons	and	the	dorsal	root	ganglia	[41,42]	
and	confirmed	that	Kpc2-stained	cells	were	also	positive	for	Iselt-1/2	(Figure	2F,	H,	J).	It	is	important	to	
notice	 that	 a	 few	 cells	 were	 autofluorescent	 (to	 discriminate	 autofluorescent	 cells	 from	 Islet-1/2	
stained	cells,	see	Supplemental	Figure	2).		









In	 conclusion,	 these	 results	 highlight	 that	 the	 expression	 of	 Kpc2	 and	 Hoxa2	 overlap	 during	 mouse	
embryogenesis	 between	 E8.5	 and	 E12.5.	 The	 Kpc2	 expression	 pattern	 is	 restricted	 and	 in	 particular	
pertains	 to	 the	 motor	 neurons,	 the	 dorsal	 root	 ganglia,	 the	 facio-acoustic	 (VII-VIII)	 ganglion	 complex	
and	the	superior	and	inferior	glossopharyngeal	nerve	(IX).		
HOXA2	 has	 a	 short	 half-life	 and	 is	 targeted	 for	 proteasomal	 degradation	 independently	 of	 the	 KPC	
complex.	
Since	 KPC2	 interacts	 with	 HOXA2,	 it	 appeared	 reasonable	 to	 hypothesize	 that	 HOXA2	 ubiquitination	
state	and/or	stability	might	be	regulated	by	KPC2.	To	precisely	look	into	the	HOXA2	stability,	we	started	
by	 quantifying	 HOXA2	 half-life.	 HEK293T	 cells	 transiently	 transfected	 with	 FLAG-HOXA2	 were	 treated	
with	 cycloheximide	 (CHX)	 (200µg/ml)	 to	 inhibit	 de	 novo	 protein	 synthesis.	 Cells	 were	 collected	 at	
different	 timepoints	 (0,	 1.5,	 3	 and	 4.5h)	 and	 protein	 lysates	 were	 analyzed	 by	 Western	 blotting.	 As	
shown	 in	 Figure	 3A,	 the	 level	 of	 HOXA2	 quickly	 decreased	within	 3h	 of	 CHX	 treatment.	 Densitometry	
analysis	 normalized	 to	 β-actin	 levels	 indicated	 that	 HOXA2	 half-life	 was	 about	 3.7	 ±	 0.42h	
demonstrating	that	HOXA2	is	a	short-lived	protein	in	this	cell	context.	
To	 further	address	whether	 the	proteasome	contributes	 to	 the	HOXA2	decay	and	 therefore	conditions	
its	short	half-life,	HOXA2	levels	were	assessed	in	the	presence	of	proteasome	inhibition.	HEK293T	cells	
were	 pre-treated	 with	 the	 proteasome	 inhibitor	 MG132	 for	 4h	 before	 adding	 CHX,	 and	 harvested	 at	
different	 timepoints.	 As	 a	 consequence,	 the	 quick	 decrease	 in	 HOXA2	 was	 no	 longer	 observed,	 the	
protein	 still	 appearing	 abundant	 after	 4.5	 h,	 a	 time	 at	which	HOXA2	 became	 barely	 detectable	 in	 the	
absence	 of	 proteasome	 inhibition	 (Figure	 3A).	 These	 data	 strongly	 support	 that	HOXA2	 is	 a	 target	 for	
proteasomal	degradation.		
It	 is	 of	 note	 that	 three	 distinct	 forms	 of	 FLAG-HOXA2	 protein	 could	 be	 detected	 and	 that	 a	 shift	 in	
relative	band	intensity	was	observed	between	the	examined	timepoints.	Indeed,	while	comparing	band	
patterns	between	0	and	1.5h	timepoints,	the	lowest	band,	which	is	the	most	abundant	at	first,	becomes	
weaker	 while	 the	 upper	 band	 becomes	 more	 intense.	 At	 later	 timepoints,	 the	 upper	 band	 remains	
predominant	while	 the	 lower	 ones	 progressively	 fade	 down	 to	 become	 hardly	 detected.	 The	 heaviest	
form	 is	 the	 last	 to	disappear	between	3h	and	4.5h	of	CHX	 treatment.	Together	 these	observations	are	
suggestive	 of	 a	 conversion	 of	 the	 smaller	 Hoxa2	 forms	 into	 the	 heavier	 one	 prior	 to	 proteasome-
mediated	degradation.	This	also	suggests	that	the	stability	versus	decay	of	Hoxa2	 is	regulated	by	post-
translational	modifications.		
Next,	 we	 tested	 whether	 the	 interaction	 with	 KPC2	 induces	 HOXA2	 destabilization.	 To	 this	 end,	 we	




of	HOXA2	 could	 be	modulated	by	 KPC2.	 Cells	were	 treated	with	 the	 proteasomal	 inhibitor	MG132	 for	
15h	before	harvest.	 Several	higher	molecular	weight	bands	associated	 to	 the	FLAG	tag	were	detected,	
presumably	 corresponding	 to	 ubiquitine-conjugated	 forms	 of	 HOXA2.	 In	 an	 attempt	 to	 confirm	 the	
molecular	 identity	 of	 these	 bands,	 His-tagged	 ubiquitin	 was	 overexpressed	 together	 with	 HOXA2.	




the	 catalytic	 subunit	 of	 the	 complex	 whereas	 KPC2	 was	 shown	 to	 stabilize	 KPC1,	 to	 recruit	
polyubiquitinated	proteins	and	to	interact	with	the	26S	proteasome,	i.e.	KPC2	acts	as	an	adapter	in	the	
KPC	 complex.	 Whether	 KPC1	 and	 KPC2	 together	 were	 involved	 in	 mediating	 HOXA2	 decay	 was	 then	
addressed.	Again,	the	HOXA2	abundance	did	not	appear	to	be	diminished	upon	expression	of	both	KPC	





HOXA2	 transcriptional	activity.	Hoxa2	 transcriptional	activity	was	 tested	by	a	 luciferase	 reporter	assay	
in	 HEK293T	 cells.	 A	 reporter	 construct	 containing	 a	 Hox	 responsive	 element	 was	 transfected	 in	
combination	with	vectors	coding	for	Hoxa2	and	GST-KPC2.	Moreover,	expression	vectors	for	the	Hoxa2	
cofactors,	PBX1a	and	PREP1,	were	added	to	provide	a	full	activation	of	the	reporter	[35].	As	a	result,	we	
observed	a	 significant	activation	 induced	by	Hoxa2.	Moreover,	we	observed	 that	 the	activity	of	Hoxa2	




Since	 KPC2	 expression	 negatively	 impacts	 on	 the	HOXA2	 activity	 but	 does	 not	 stimulate	 its	 decay,	we	
next	 examined	 the	 cellular	 localization	 of	 the	 both	 proteins	 as	 well	 as	 of	 their	 interaction.	 Whereas	
HOXA2	 mainly	 exhibited	 a	 diffuse	 nuclear	 distribution,	 KPC2	 was	 mainly	 shown	 to	 be	 present	 in	 the	
cytoplasm	(Figure	5A-B).		




terminally	 to	 the	 173th	 amino	 acid	 (VN173),	 while	 the	 second	 is	 C-terminally	 fused	 to	 the	 C-terminal	
moiety	 of	 Venus	 (amino	 acids	 155	 to	 243;	 VC155).	 Fluorescence	 emission	 not	 only	 validate	 the	 direct	







and	VC155KPC2	 fusion	proteins	provided	a	diffuse	or	punctuated	 fluorescence	 in	 the	 cytoplasm	 (Figure	
5C).	 Surprisingly,	 for	 the	VN173p27Kip1-VC155KPC2	combination,	 the	vast	majority	of	 the	emitted	 signal	
was	 localized	 in	the	nucleus	(Figure	5C).	 It	was	previously	suggested	that	p27Kip1,	once	exported	from	
the	 nucleus,	 interacts	 and	 is	 ubiquitinated	 by	 the	 KPC	 complex	 [27,28].	 However,	 our	 results	 suggest	
that	the	KPC2-p27Kip1	interaction	already	takes	place	in	the	nucleus.		
The	HOXA2	ORF	was	fused	downstream	VN173	(VN173HOXA2),	and	tested	in	BiFC	with	VC155KPC2.	 In	this	
case,	 the	 emitted	 signal	 appeared	 distributed	 both	 in	 the	 nucleus	 and	 in	 the	 cytoplasm	 (Figure	 5C).	
Again	 as	 negative	 controls,	 the	 VN173HOXA2/VC155,	 VN173/VC155KPC2	 and	 VN173/VC155	 combinations	
showed	 no	 or	 very	 weak	 fluorescence	 compared	 to	 the	 corresponding	 test	 condition	
VN173HOXA2/VC155KPC2	(Supplemental	Figure	3).	As	mentioned	above,	HOXA2	was	mainly	nuclear	when	
expressed	alone,	but	its	interaction	with	KPC2	showed	a	positive	cytoplasmic	signal	in	BiFC.	This	opened	
the	 possibility	 that	 HOXA2	 could	 be	 relocalized	 upon	 KPC2	 interaction.	 The	 HOXA2	 localization	 was	
examined	 by	 immunofluorescence	 in	 the	 COS-7	 cell	 line,	 in	 the	 absence	 or	 the	 presence	 of	 KPC2.	
VN173HOXA2	was	transiently	 transfected	 in	combination	with	VC155KPC2	or	not.	As	shown	 in	Figure	6A,	
when	 expressed	 alone	 VN173HOXA2	 exhibited	 a	 diffuse	 or	 punctuated	 nuclear	 distribution.	 However,	
transfection	 of	 VC155KPC2	 produced	 a	 striking	 redistribution	 of	 VN173HOXA2	 towards	 the	 cytoplasm	
(Figure	 6A).	 Quantification	 of	 the	 HOXA2	 distribution	 measured	 using	 imageJ	 software	 confirmed	 a	
significant	 redistribution	 of	 HOXA2	 in	 the	 cytoplasm	 upon	 KPC2	 expression	 (Figure	 6B).	 These	 results	
suggest	that	KPC2	can	modulate	HOXA2	subcellular	localization	and	sequester	HOXA2	in	the	cytoplasm.	
Whether	HOXA2	 is	sequestered	 in	the	cytoplasm	by	KPC2	right	after	 its	 translation	or	shuttled	back	to	
the	cytoplasm	after	entering	 the	nucleus	was	 the	next	 issue.	To	answer	 this	question,	we	 investigated	




(LMB).	 LMB	 is	 a	 drug	 known	 to	 prevent	 nuclear	 export	 of	many	 proteins	 by	 inhibiting	 the	 function	 of	
CRM1,	 a	 receptor	 of	 nuclear	 export	 signals.	 Whereas	 immunofluorescence	 revealed	 that	 HOXA2	 is	
mainly	nuclear,	a	small	fraction	of	the	signal	was	also	detected	in	the	cytoplasm.	A	16h	incubation	with	
LMB	 abolished	 this	 staining	 corresponding	 to	 the	 cytoplasmic	 HOXA2	 suggesting	 that	 the	 cytoplasmic	
fraction	of	HOXA2	translocates	from	the	nucleus	(Figure	6A).	Moreover,	LMB	treatment	did	not	prevent	
the	 KPC2-HOXA2	 interaction	 to	 take	 place,	 but	 the	 signal	 now	 appeared	 to	 be	 massively	 nuclear.	
Therefore,	 LMB	 prevented	 the	 interaction	 from	 translocating	 to	 the	 cytoplasm	 (Figure	 6A).	 These	
results	were	 quantified	 as	 the	 relative	 nucleus/cytoplasm	 BiFC	 fluorescence	 ratio.	 As	 shown	 in	 Figure	
6C,	 LMB	 treatment	 clearly	 reduced	 the	 cytoplasmic	 interaction	 of	 KPC2	 and	 HOXA2.	 This	 together	
supports	that	the	HOXA2	and	KPC2	proteins	first	associate	in	the	nucleus	before	being	shuttled	back	to	




deletion	 variants	 where	 residues	 from	 the	 N-terminal	 (Hoxa2ΔN	 [138-372]),	 C-terminal	 (Hoxa2ΔC	 [1-




observed	with	Hoxa2HD	 and	KPC2	 suggesting	 that	 the	homeodomain	alone	 is	 sufficient	 to	mediate	 the	
interaction.	 In	 accordance	 with	 this	 observation,	 Hoxa2ΔN	 and	 Hoxa2ΔC,	 both	 containing	 the	
homeodomain,	 also	 interact	 with	 KPC2.	 Moreover,	 Hoxa2ΔHD	 was	 also	 shown	 to	 mediate	 KPC2	
interaction	suggesting	that	a	domain	different	from	the	HD	contributes	to	KPC2	binding.		
Interestingly,	 although	 all	 Hoxa2	 variants	 but	 Hoxa2ΔHD	 lacking	 the	 homeodomain	 showed	 a	 nuclear	
localization	 (Supplemental	 Figure	 4),	 the	 BiFC	 signal	 emitted	 upon	 interaction	 with	 KPC2	 displayed	
distinct	 intracellular	 distribution	 according	 to	 the	 Hoxa2	 variant.	 Indeed,	 whereas	 Hoxa2ΔC	 provided	
both	 nuclear	 and	 cytoplasmic	 BiFC	 fluorescence,	 Hoxa2ΔN	 and	 Hoxa2HD	 presented	 exclusively	 nuclear	
interaction	signals.	This	suggests	that	a	region	 located	 in	the	N-terminal	part	of	Hoxa2	 is	necessary	for	




in	 a	 short	 discrete	 protein	motive	 but	 are	 rather	 spread	 among	 at	 least	 two	 severable	 Hoxa2	 protein	
regions.	In	addition,	since	all	Hoxa2	deletion	variants	tested	conserved	the	ability	to	interact	with	KPC2,	
one	 can	 conclude	 that	 distinct	 subsets	 of	molecular	 contacts	 are	 sufficient	 to	 support	 the	 interaction	
with	KPC2	(Figure	7).	Finally,	 the	N-terminal	 region	of	Hoxa2	 is	 required	for	 its	KPC2-mediated	nuclear	
export.	
KPC2	binding	is	common	to	HOX	proteins	
Based	 on	 the	 finding	 that	 the	 homeodomain	 of	 Hoxa2	 contributes	 to	 the	 interaction	 with	 KPC2,	 and	
considering	 HOX	 proteins	 share	 important	 sequence	 identity	 in	 their	 homedomain,	 we	 addressed	
whether	HOX	proteins	other	than	HOXA2	were	capable	of	interacting	with	KPC2.	Different	HOX	proteins	
from	 distinct	 paralogue	 groups	 were	 tested	 for	 their	 KPC2	 binding	 properties	 by	 BiFC.	 All	 the	 tested	
proteins	 (HOXA1,	 HOXB1,	 HOXB2,	 HOXA3,	 HOXC4,	 HOXB5,	 HOXD10	 and	 HOXC11)	 showed	 fluorescent	
signal	 (Figure	 8).	 However,	 the	 pattern	 of	 BiFC	 signal	 differed	 according	 to	 the	 HOX	 involved.	 While	
HOXA1,	HOXB1	HOXA3,	HOXC4	and	HOXB5	mainly	showed	a	clear	nuclear	 interaction,	HOXB2,	HOXD10	
and	 HOXC11	 like	 HOXA2,	 mainly	 interacted	 with	 KPC2	 in	 the	 cytoplasm	 (Figure	 8).	 These	 distinctive	




Hox	 proteins	 play	 important	 roles	 in	mammalian	 development	 as	 well	 as	 organ	 homeostasis	 and	 cell	
differentiation	 at	 adulthood.	 As	 transcription	 factors,	 their	 transcriptional	 activity	 should	 be	 finely	
tuned	 to	 properly	 control	 the	 vast	 range	 of	 processes	 under	 their	 control.	 In	 fact,	 Hox	 proteins	 have	
been	shown	 to	display	versatile	activities	according	 to	 the	multiple	cellular	 contexts	 they	are	 involved	
in	[4]	and	subtle	deregulation	of	Hox	expression	can	alter	development	processes	or	cell	fates	and	lead	
to	malformations	or	pathologies	[44].	At	a	protein	level,	intra-cellular	localization	or	stabilization	versus	
degradation	 are	 ways	 to	 control	 transcription	 factor	 activities	 which	 have	 barely	 been	 addressed	 for	
Hox	proteins.	 In	 this	paper,	we	 identified	the	ubiquitin-ligase	adapter	protein	KPC2	as	 interacting	with	
HOXA2	and	influencing	its	transcriptional	activity	and	intracellular	localization.		
While	 looking	 for	 Hoxa2-interacting	 proteins	 susceptible	 to	 modulate	 Hoxa2	 activity,	 a	 large-scale	
yeast-two	 hybrid	 screen	 allowed	 identifying	 candidate	 interactors	 among	 which	 the	 KPC2	 protein,	 a	
KPC-ubiquitin-ligase	 complex	 component.	 The	 KPC2-HOXA2	 interaction	 was	 further	 confirmed	 by	 two	
complementary	 methods,	 namely	 co-precipitation	 and	 BiFC,	 to	 occur	 in	 mammalian	 cells.	 As	 being	
involved	in	an	ubiquitin-ligase	complex,	KPC2	was	hypothesized	to	negatively	influence	HOXA2	stability.	
The	ubiquitine-proteasome	machinery	 indeed	controls	 transcription	 factors	by	 fine-tuning	 their	 steady	
state	and	inducing	their	degradation	when	their	function	is	no	longer	appropriate	and	we	showed	here	
that	 HOXA2	 is	 a	 short-lived	 protein	 that	 is	 indeed	 regulated	 by	 the	 proteasome.	 However,	 the	 short	
half-life	 and	 rapid	 decay	 of	 HOXA2	 seems	 independent	 of	 the	 KPC	 complex	 since,	 KPC2	 or	 KPC1-KPC2	
were	 not	 shown	 to	 induce	 the	 degradation	 of	 HOXA2.	 Nonetheless,	 we	 further	 showed	 that	 KPC2	
expression	 caused	 a	 drop	 in	 Hoxa2	 transcriptional	 activity	 which	 could	 be	 associated	 with	 its	 escape	
from	 the	 nucleus	 and	 redistribution	 in	 the	 cytoplasm.	 In	 addition,	while	 inhibiting	 the	 nuclear	 export	
protein	pathway	mediated	by	CRM1,	 the	KPC2-HOXA2	 interaction	 is	almost	exclusively	detected	 in	 the	
nucleus,	whereas	it	shows	both	a	nuclear	and	cytoplasmic	pattern	in	the	absence	of	inhibition.	Together	
this	 supports	 (i)	 that	 the	newly	 identified	HOXA2-KPC2	 interaction	 first	 takes	 place	 in	 the	nucleus,	 (ii)	
that	KPC2	promotes	the	export	of	HOXA2	out	of	the	nucleus	and	(iii)	 that	 this	 relocalization	correlates	
with	a	decrease	in	HOXA2	activity.	
Currently,	 except	 the	 proteasomal	 degradation	 of	 p27Kip1,	 no	 other	 role	 has	 been	 described	 for	 the	
KPC	 complex.	 The	 KPC2-p27Kip1	 interaction	 was	 suggested	 to	 take	 place	 in	 the	 cytoplasm	 where	
p27Kip1	proteolysis	takes	place	[27-29].	Surprisingly,	 the	BiFC	assay	presented	here	highlights	that	the	
interaction	 mediated	 between	 KPC2	 and	 p27Kip1	 was	 mainly	 nuclear.	 On	 the	 other	 hand,	 HOXA2,	
known	 to	 be	 mainly	 nuclear,	 was	 notably	 shown	 to	 interact	 with	 KPC2	 in	 the	 cytoplasm.	 For	 both	
p27Kip1	and	HOXA2,	their	interaction	with	KPC2	localized	in	unexpected	subcellular	compartments.	We	
suggest	 that	 KPC2	 might	 be	 a	 shuttling	 protein	 involved	 in	 the	 redistribution	 of	 its	 partners.	 In	 this	
model,	KPC2	would	enter	the	nucleus,	bind	p27Kip1	and/or	HOXA2	and	participate	to	their	cytoplasmic	
export.		
In	 that	context,	ubiquitine	 ligases	and	the	subsequent	ubiquitination	process	were	reported	to	 lead	to	
substrate	 regulation	 independently	 of	 their	 proteasomal	 proteolysis.	 For	 example,	 ubiquitination	 can	
regulate	 the	 recruitment	 of	 partners,	 induce	 nuclear	 entry	 or	 modify	 transcription	 factor	 activity	 by	
regulating	their	DNA	binding	both	in	positive	or	negative	way	(reviewed	in	[45]).	In	particular,	functions	
unrelated	 to	 the	proteasome-mediated	degradation	have	already	been	 reported	 for	UBA-UbL	proteins	
family.	Proteins	of	this	family,	which	includes	KPC2	[28],	display	UBA	and	UbL	domains	able	to	 interact	
with	 ubiquitinated	 substrates	 and	 subunits	 of	 the	 proteasome,	 respectively.	 UBA-UbL	 proteins	 have	
been	proposed	to	act	as	shuttle-factors	 involved	 in	the	substrate	degradation	while	delivering	them	to	
the	 proteasome.	 However,	 in	 addition	 to	 their	 role	 in	 proteasome-mediated	 degradation	 of	 their	
substrates,	 functions	 in	 autophagy,	 endocytosis,	 exocytosis,	 nucleotide	 excision	 repair,	 spindle	 pole	
body	 duplication	 or	 cell	 growth	 have	 been	 highlighted	 for	UBA-UbL	 proteins	 (reviewed	 in	 [46]).	More	
precisely,	 Plic-1	 belonging	 to	 this	 family,	was	 shown	 be	 involved	 in	 the	 aggresome	 formation	 [47],	 to	
interact	with	polyubiquitinated	TDP-43	causing	 its	 redistribution	and	 increasing	 its	presence	 in	TDP-43	
aggregates	 [48].	 Consequently,	 UBA-UbL	 proteins	 previously	 reported	 as	 shuttle-factors	 between	
substrate	 proteins	 and	 the	 proteasome,	 could	 be	 more	 largely	 involved	 in	 the	 intracellular	
relocalization	of	binding	partners,	independently	of	proteasomal	targeting,	as	it	is	the	case	for	Plic1	and	
TDP-43	or	KPC2	and	HOXA2.		
Correlatively	 to	 its	 interaction	 with	 KPC2	 and	 its	 nuclear	 export,	 we	 observed	 a	 decrease	 in	 Hoxa2	
transcriptional	activity.	Indeed,	in	the	presence	of	KPC2,	a	significant	reduction	in	Hoxa2	transcriptional	
activity	was	measured.	Other	reports	show	that	transcription	factor	activities	can	be	 influenced	by	the	
regulation	 of	 their	 subcellular	 distribution.	 This	 typically	 involves	 the	 nuclear	 entry	 of	 activated	
transcription	 factors	as	a	 consequence	of	 cell-signalling	events	 like	 for	STATs,	 Smads,	Gli	or	β-catenin.	
OGT-mediated	 transcription	 factor	 glycosylation	 has	 also	 been	 reported	 to	modulate	 the	 intracellular	
distribution	and	thereby	activity	of	transcription	factors	[49,50].		Export	from	the	nucleus	has	also	been	
reported	to	modulate	transcription	factor	activity.	For	example,	Snail	functions	have	been	shown	to	be	
controlled	by	 its	 intracellular	 localization.	 Indeed,	phosphorylation	on	a	 serine	 rich	 sequence	adjacent	
to	 its	 NES	 exports	 Snail	 from	 the	 nucleus	 by	 a	 CRM1-dependent	 mechanism.	 This	 shift	 out	 of	 the	
nucleus	 consequently	 blocks	 Snail	 access	 to	 the	 target	 promoters	 [51].	 The	 nuclear	 export	 of	 the	
homeodomain	transcription	factor	Engrailed	has	been	associated	to	its	atypical	secretion	out	of	the	cell	
[52].	 To	 our	 knowledge,	 the	 regulated	 nuclear	 export	 of	 a	 Hox	 protein	 has	 never	 been	 reported.	
However,	the	nucleocytoplasmic	shuttling	of	TALE	proteins	which	regulate	Hox	protein	activity	and	DNA	
binding	specificity	has	been	 identified	as	a	way	to	modulate	Hox	function	 in	a	context-specific	manner	
[53].	 Conversely,	 Hox	 proteins	 can	 also	 be	 viewed	 as	 context-specific	modulators	 of	more	 pleiotropic	
transcription	factors.	Recently,	Hoxa2	was	shown	to	influence	the	fate	of	branchial	arches	by	regulating	
Meis	 DNA	 binding	 to	 specific	 sites	 [9].	 The	 nucleocytoplasmic	 shuttling	 of	 Hoxa2	 could	 contribute	 to	
such	 context-specific	 modulation	 of	 TALE	 protein	 activity.	 Consistently,	 we	 showed	 that	 KPC2	 is	
expressed	with	 a	 restricted	pattern	 during	mouse	 embryogenesis.	 Indeed,	motor-neurons,	 dorsal	 root	
ganglia	 and	 ganglion	 (VII-IX)	 were	 reproducibly	 stained	 in	 ISH,	 a	 pattern	 in	 accordance	 with	 results	
provided	 in	 the	 Edinburgh	 Mouse	 Atlas	 of	 Gene	 Expression	 (EMAGE,	
http://www.emouseatlas.org/emage/home.php).	 Indeed,	 at	 E14.5,	 Kpc2	 showed	 a	 strong	 staining	 for	
dorsal	 root	 ganglia	 and	 a	moderate	 signal	 in	 different	 ganglia	 (V-X)[54].	 The	 Kpc2	 expression	 pattern	
overlaps	with	 that	 of	Hoxa2	which	 supports	 that	 Kpc2	 could	 regulate	Hoxa2	 transcriptional	 activity	 in	
specific	contexts	in	vivo.	
To	 test	 whether	 HOXA2	 redistribution	 induced	 by	 KPC2	 is	 a	 consequence	 of	 the	 direct	 interaction	
between	 HOXA2	 and	 KPC2,	 we	 constructed	 several	 Hoxa2	 deletions	 derivatives	 which	 lack	 the	
homeodomain	 or	 the	 C	 and/or	 N	 terminal	 region	 of	 the	 homedomain.	 Since	 all	 the	 tested	 deletion	
derivatives	 still	 interact	with	KPC2,	our	data	 indicate	 that	 the	KPC2-Hoxa2	 interaction	 require	motives	
spread	 among	 at	 least	 2	 regions:	 the	 homeodomain	 and	 the	 C-	 or/and	N-terminal	 domain.	Moreover,	
our	data	support	that	the	N-terminal	part	of	Hoxa2	is	actually	required	for	 its	KPC2-dependent	nuclear	
export.		
Since	the	homeodomain	 is	 involved	 in	the	 interaction	with	KPC2	and	 is	conserved	 in	HOX	proteins,	the	
question	 arose	 whether	 KPC2	 could	 interact	 with	 all	 HOX	 proteins.	 Nine	 HOX	 proteins	 were	 tested	
which	 all	 interact	 with	 KPC2.	 However,	 we	 found	 that	 these	 interactions,	 contrarily	 to	 what	 was	
observed	for	Hoxa2,	do	not	always	take	place	in	both	the	nucleus	and	the	cytoplasm.	Rather,	for	some	




In	 summary,	we	 identified	 KPC2	 as	 a	 new	 interactor	 of	Hoxa2	 and	provided	 evidence	 that	 KPC2	 could	









Figure	 1.	 Hoxa2	 interacts	 with	 KPC2.	HEK293T	 cells	 were	 co-transfected	 with	 expression	 vectors	 for	





Figure	 2.	 Kpc2	 and	Hoxa2	 expression	 patterns	 overlap	 during	 mouse	 embryogenesis.	 (A)	 Schematic	
representation	 of	 Kpc2	 mRNA	 and	 localization	 of	 the	 PCR	 primers	 used	 to	 amplify	 sequences	
corresponding	 to	 the	 three	mRNA	 isoforms	 (X1,	 X2	 and	X3).	Numbered	boxes	 (1	 to	 10)	 correspond	 to	
the	 Kpc2	 exons.	 “Start”	 and	 “Stop”	 indicate	 the	 relative	 position	 of	 the	 translation	 initiation	 and	
termination	 codons,	 respectively.	 (B)	 Detection	 of	 Hoxa2,	 Kpc2	 and	 β-Actin	 transcripts	 from	 E8.5	 to	
E12.5	 embryos	 by	 RT-PCR.	 Arrowheads	 indicate	 the	 amplicons	 corresponding	 to	 the	 X1,	 X2	 and	 X3	
mRNA	 isoforms.	 (C-D)	 In	 situ	 hybridizations	 of	Kpc2	 on	 sagittal	 cryosection	 of	 E10.5	 and	 E11.5	mouse	
embryos.	 (E-J)	Sagittal	and	transversal	cryosections	of	E11.5	mouse	embryos	hybridized	for	Kpc2	 (E,	G,	
I)	 and	 immunolabeled	 for	 Iselt-1/2	 (red)	 (F,	 H,	 J).	 (K-R)	 In	 situ	 hybridization	 of	 Kpc2	 (K,M,O,	 Q)	 and	
Hoxa2	(L,	N,	P,	R)	mRNAs	on	sagittal	and	transversal	cryosections	of	E10.5.	(S-V)	In	situ	hybridization	of	
Kpc2	(S,	U)	and	Hoxa2	(T,	V)	mRNAs	on	sagittal	and	transversal	cryosections	of	E11.5.Black	arrows	show	
facio-acoustic	 (VII-VIII)	 neural	 crest	 complex;	 red	 arrows	 show	 the	 superior	 and	 inferior	
glossopharyngeal	nerve	 (IX);	green	arrows	show	the	dorsal	 root	ganglia	and	an	orange	arrow	 indicates	
the	boundary	between	the	r1	and	r2	rhombomeres.	Spinal	cord	transverse	sections	(G,	H,	Q,	R,	U,	V)	are	
surrounded	by	dashed	line.	OV,	otic	vesicle;	RP,	Rathke’s	pouch.	Scale	bar	=	100	µm	
Figure	 3.	 HOXA2	 is	 a	 short-lived	 protein	 regulated	 by	 the	 proteasome	 independently	 of	 the	 KPC	
complex.	 (A-C)	HEK293T	cells	were	co-transfected	with	expression	vectors	coding	for	FLAG-HOXA2	and	
GST-KPC2,	GST-KPC1	 or	GST.	 Cell	 lysates	were	 then	 subjected	 to	 immunoblot	 analysis	with	 antibodies	
against	 FLAG,	 GST	 and	 β-ACTIN.	 (A-B)	 To	 determine	 the	 HOXA2	 half-life,	 cells	 were	 treated	 with	
cycloheximide	 (CHX)	 for	 the	 indicated	 time.	 The	 involvement	 of	 the	 proteasome	 in	 the	 RCHY1	






Hoxa2-mediated	 reporter	 activation.	 The	 relative	 activity	 of	 the	 Luc	 reporter	 was	 quantified	 by	
luminometric	 assays	 for	 the	 luciferase	 (Luc)	 and	 galactosidase	 (Gal)	 enzymes	 and	 is	 presented	 as	 a	
Luc/Gal	activity	ratio.	The	Luc/Gal	relative	activity	corresponding	to	the	“GST	alone”	condition	was	set	
as	 the	 reference	 of	 “1”.	 Bars	 indicate	 the	 standard	 deviation	 (N=4,	 n=12-15).	 Asterisks	 indicate	 a	
significant	impact	of	GST-KPC2	on	the	Hoxa2	activity	(NS,	non	significant,	***	p	<	0.0001).	
Figure	5.	Bimolecular	 Fluorescence	Complementation	 (BiFC)	 reveals	KPC2	and	HOXA2	 interact	 in	 the	
nucleus	 and	 the	 cytoplasm.	 COS-7	 cells	 were	 transfected	 with	 FLAG-HOXA2	 (A)	 or	 GST-KPC2	 (B)	 and	
subjected	 to	 immunocytochemistry	 with	 anti-FLAG	 and	 anti-GST	 respectively.	 (C)	 Bimolecular	
Fluorescence	 Complementation	 assay	 reveals	 the	 interactions	 in	 culture	 cells.	 COS-7	 cells	 were	
transfected	with	 VN173KPC1,	 VN173p27kip1	 or	 VN173Hoxa2	 and	 VC155KPC2	 coding	 vectors,	 as	 indicated.	
Upon	 interaction	between	the	partner	proteins,	 the	VN173	and	VC155	moieties	of	 the	Venus	 fluorescent	
protein	brought	together	provide	a	fluorescent	signal.	Nuclei	were	stained	with	DAPI	(blue).	









Hoxa2	 deletion	 derivatives.	 Deletions	 were	 generated	 in	 the	 Hoxa2	 sequence	 to	 remove	 amino-acids	
(aa)	1	to	137	at	the	N-terminal	side	[Hoxa2ΔN	(138-372)],	aa	199	to	372	at	the	C-terminal	side	[Hoxa2ΔC	
(1-198)],	 the	 homeodomain	 [Hoxa2ΔHD(Δ139-198)],	 or	 all	 but	 the	 homeodomain	 [Hoxa2HD(139-198)]	
(HD,	 homeodomain;	 HX,	 hexapeptide).	 (B)	 COS-7	 cells	were	 transfected	with	 different	 combination	 of	
vectors	coding	for	VN173Hoxa2	or	VN173Hoxa2	deletion	mutants	and	VC155KPC2.	Nuclei	were	stained	with	
DAPI	(blue).	
Figure	 8.	 HOX	 proteins	 share	 the	 capacity	 to	 interact	 with	 KPC2.	 COS-7	 cells	 were	 transfected	 with	
different	 combination	 of	 vectors	 coding	 for	 VN173HOX	 and	 VC155KPC2	 for	 BiFC	 analysis.	 Nuclei	 were	
stained	with	DAPI	(blue).		
Supplemental	 Figure	 1.	Different	Kpc2	 isoforms	 are	 expressed	during	mouse	 embryogenesis.	RT-PCR	
were	 performed	 on	 different	 cDNA	 pool	 of	 embryos	 between	 E8.5	 and	 E12.5.	 PCR	 products	 were	
isolated,	purified	and	sequenced.		
Supplemental	 Figure	 2.	 Distinction	 between	 Iselt-1/2	 stained	 and	 autofluorescent	 cells.	 Sagittal	
cryotsections	of	E11.5	mouse	embryos	were	immunolabeled	with	anti-Iselt-1/2	primary	antibody	and	an	
Alexa	 Fluor®555	 anti-mouse	 IgG	 secondary	 antibody.	 The	 Iselt-1/2	 fluorescent	 signal	 was	 observed	 in	
the	 red	 channel.	 Autofluorescent	 cells	 were	 detected	 in	 both	 red	 (left	 pictures)	 and	 green	 channels	
(right	pictures).	
Supplemental	 Figure	 3.	 KPC2	 and	 HOXA2	 interact	 both	 in	 the	 cytoplasm	 and	 in	 the	 nucleus.	 COS-7	
cells	 were	 transfected	 with	 vectors	 coding	 for	 VN173HOXA2	 and	 VC155KPC2;	 VN173	 and	 VC155KPC2;	
VN173HOXA2	 and	 VC155;	 VN173	 and	 VC155.	 Only	 the	 VN173HOXA2	 and	 VC155KPC2	 combination	 provides	 a	
BiFC	signal.	Nuclei	were	stained	with	DAPI	(blue).		
Supplemental	 Figure	 4.	 Subcellular	 localization	 of	 Hoxa2	 deletion	 derivatives.	 HEK293T	 cells	 were	




















































Actin	 CCACCATGTACCCAGGCATT	 AGGGTGTAAAACGCAGCTCA	 57	 253	
Hoxa2	 AGACCTCGACGCTTTCACAC	 TGGTTTTCCTTGCACTGGGT	 55	 499	
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